Neuberger Berman Group LLC Cabaletta Bio, Inc. Transaction History
Neuberger Berman Group LLC
- $114 Billion
- Q1 2025
A detailed history of Neuberger Berman Group LLC transactions in Cabaletta Bio, Inc. stock. As of the latest transaction made, Neuberger Berman Group LLC holds 10,565 shares of CABA stock, worth $23,031. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,565Holding current value
$23,031% of portfolio
0.0%Shares
3 transactions
Others Institutions Holding CABA
# of Institutions
99Shares Held
37.8MCall Options Held
154KPut Options Held
192K-
Black Rock Inc. New York, NY4.76MShares$10.4 Million0.0% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD3.97MShares$8.65 Million0.0% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA3.63MShares$7.92 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.84MShares$6.2 Million0.0% of portfolio
-
Bain Capital Life Sciences Investors, LLC Boston, MA2.76MShares$6.02 Million1.29% of portfolio
About Cabaletta Bio, Inc.
- Ticker CABA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,014,000
- Market Cap $63.3M
- Description
- Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor (CAAR) T cells that are designed to selectively bind and eliminate B cells, which produce di...